Avanos Medical Inc (AVNS)

Debt-to-equity ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 828,500 1,229,700 1,222,000 1,227,900 1,236,300 1,222,100 1,234,800 1,298,700 1,291,200 1,263,500 1,251,600 1,256,500 1,263,900 1,261,900 1,296,300 1,252,600 1,256,500 1,289,900 1,261,600 1,256,500
Debt-to-equity ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2024 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $828,500K
= 0.00

The debt-to-equity ratio for Avanos Medical Inc has consistently been 0.00 for the periods from March 31, 2020, to December 31, 2024. A debt-to-equity ratio of 0.00 typically indicates that the company has no debt or a negligible amount in comparison to its equity. This implies that the company is primarily funded by equity rather than debt, which can be considered a positive indicator of financial stability and strength. A lower debt-to-equity ratio is generally perceived favorably by investors and creditors as it signifies lower financial risk and leverage. This stable ratio over the years suggests that Avanos Medical Inc has maintained a conservative capital structure, which may be advantageous in terms of financial flexibility and risk management.